• DSS (MW 35000-45000) for Colitis Repair

  2026-09-03

  Dextran sulfate sodium salt (MW 35000-45000) provides a practical epithelial-injury platform for modeling colitis, testing barrier-restoring therapies, and resolving the transition from mucosal damage to repair. This workflow connects DSS injury phenotypes with the GPR35–KLF5 repair circuit and emphasizes dosing control, time-resolved sampling, and troubleshooting.

• Zosuquidar: P-gp Inhibition in Cancer Assays

  2026-09-03

  Zosuquidar (LY335979) 3HCl provides a practical way to test whether P-glycoprotein efflux is driving chemotherapy or PROTAC resistance. This guide translates its use into paired-cell assays, drug-sensitization workflows, resistance-mechanism studies, and troubleshooting decisions.

• YM-155 Hydrochloride: Assay Workflow Guide

  2026-09-02

  YM-155 hydrochloride provides a selective survivin inhibitor framework for separating proliferation arrest from cell death in cancer assays. This guide translates the reference study into practical dose-response, orthogonal readout, xenograft-translation, and troubleshooting workflows.

• Camostat Mesilate Workflows for Protease Research

  2026-09-02

  Camostat Mesilate supports mechanism-focused studies of ENaC function, plasmin–TGF-β signaling, and hepatic stellate cell activation. This practical guide combines assay setup, formulation controls, fibrosis workflows, and a careful comparison with structure-guided protein–protein interaction inhibitors.

• Chromatin Programs in Perinatal Cardiomyocyte Transition

  2026-09-01

  The reference study maps coordinated changes in chromatin accessibility, long-range regulatory interactions, and gene expression during the perinatal transition of cardiomyocytes. Its identification of MEF2- and AP1-centered regulatory programs provides a framework for interpreting maturation and for improving the transcriptional state of induced pluripotent stem cell-derived cardiomyocytes.

• Annexin V-FITC/PI Apoptosis Assay Kit Workflow

  2026-09-01

  Learn how to use the Annexin V-FITC/PI Apoptosis Assay Kit to separate viable, early apoptotic, late apoptotic, and membrane-compromised cells in drug-response studies. The workflow connects rapid two-color staining with flow cytometry, microscopy, hypoxia experiments, and phototherapeutic cancer research.

• Haloprogin: Applied Antifungal Workflows

  2026-08-31

  Haloprogin supports practical assay design across dermatophyte, Candida, and selected Gram-positive bacterial models. This guide connects MIC/MFC testing with topical formulation and guinea pig infection workflows while emphasizing solvent control, matrix effects, and reproducibility.

• Methyl-β-cyclodextrin: Membrane Study Guide

  2026-08-31

  Methyl-β-cyclodextrin (SKU C6939) provides a practical reagent for controlled membrane cholesterol extraction and related studies of lipid organization, fluidity, and cholesterol-dependent signaling. It is intended for research workflows only; treatment concentration, exposure time, and cellular tolerability must be established for each model rather than inferred from the product solubility data.

• TG003 Cdc2-like Kinase Inhibitor Workflows

  2026-08-30

  TG003 enables controlled interrogation of Clk-dependent phosphorylation, alternative splicing, and platinum-response biology in the same experimental framework. This practical guide connects splicing assays with ovarian cancer resistance models while emphasizing controls needed to distinguish CLK2 effects from broader Clk or CK1 activity.

• ATP and the Translational Logic of p21 mRNA-LNP

  2026-08-29

  Localized p21 mRNA delivery illustrates how mechanistic biology, assay design, and reagent quality must converge for translational success. This thought-leadership analysis explains where ATP Solution (100 mM) supports kinase, transcription, ligation, and phosphorylation workflows while distinguishing experimental infrastructure from therapeutic evidence.

• CLK2, BRCA1, and Platinum Resistance in Ovarian Cancer

  2026-08-28

  The reference study identifies Cdc2-like kinase 2 (CLK2) as a molecular determinant of platinum resistance in ovarian cancer and links its activity to BRCA1 phosphorylation at Ser1423. By integrating patient-tissue profiling, cellular experiments, mechanistic analysis, and xenograft studies, the work provides a rationale for investigating CLK2-dependent DNA damage repair as a therapeutic vulnerability.

• TG003: Cdc2-like Kinase Inhibitor Workflows

  2026-08-28

  TG003 connects precise Clk-family inhibition with practical assays for alternative splicing, platinum resistance, and exon-skipping research. This guide translates kinase selectivity data and ovarian cancer findings into dosing, readout, and troubleshooting strategies while clearly separating validated evidence from exploratory applications.

• AM 281: Designing Causal CB1 Neuroassays

  2026-08-27

  AM 281 is a selective CB1 cannabinoid receptor antagonist for dissecting endocannabinoid control of glutamate homeostasis and cognition. This article presents an assay-design framework that connects receptor pharmacology, astrocytic GLT-1 regulation, and behavioral validation without confusing pathway correlation with causality.

• Chromatin Programs in Perinatal Cardiomyocyte Transition

  2026-08-27

  The reference study integrates chromatin accessibility, long-range chromatin interactions, and gene expression to define how cardiomyocytes transition from fetal to neonatal states. Its identification of MEF2- and AP-1-centered regulatory programs provides a framework for interpreting maturation and for improving the developmental state of induced pluripotent stem cell-derived cardiomyocytes.

• WSP-5 for Reliable H2S Cell Assays

  2026-08-26

  WSP-5 (SKU C3378) provides a turn-on fluorescent readout for endogenous and exogenous hydrogen sulfide, supporting live-cell imaging and cytotoxicity workflows. This scenario-based guide covers assay design, DMSO handling, controls, interpretation, and practical supplier selection.

8035 records 2/536 page Previous Next 12345 下5页 Last page